Comparison of predictive performance between modified Marsh propofol model and Schnider propofol model in underweight patients
- Conditions
- Not Applicable
- Registration Number
- KCT0001502
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
1. body mass index (BMI) < 18.5 (kg/m2)
2. Hemoglobin > 9 (mg/dl)
3. Patients undergoing elective surgery under general anesthesia
1. Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive urine pregnancy test
2. Patients with known hypersensitivity to propofol or to any of the excipients
3. Clinically significant impairment of cardiovascular, respiratory and renal function
4. Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method predictive perfomrance (bias, inaccuracy, wooble divegence)
- Secondary Outcome Measures
Name Time Method adverse events